Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohortTenna Vesterman Henriksen, Claus L. Andersen, Christina Demuth et al.|Annals of Oncology|2023Cited by 71
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Claus L. Andersen, Marijana Nesic et al.|European Journal of Cancer|2024Cited by 19
Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal CancerJonas Kabel, Claus L. Andersen, Tenna Vesterman Henriksen et al.|Cancers|2023Cited by 12
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancerNadia Øgaard, Claus L. Andersen, Sarah Østrup Jensen et al.|British Journal of Cancer|2024Cited by 10
Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal CancerTenna Vesterman Henriksen, Claus L. Andersen, Christina Demuth et al.|Clinical Cancer Research|2025Cited by 7